BHU scientists secure patent for Ayurvedic formulation inhibiting over 95% Covid virus growth
BHU researchers at centre for genetic disorders also filed two international patents and received two German patents for related research.
Vagisha Kaushik | September 24, 2024 | 12:48 PM IST
NEW DELHI : Researchers from the centre for genetic orders at Banaras Hindu University (BHU) have achieved a major milestone in the fight against the SARS-CoV-2 virus, securing an Indian patent for an innovative Ayurvedic formulation that combines the phytomolecules of Ashwagandha (Withania somnifera) and Morus alba. This formulation has demonstrated over 95% effectiveness in inhibiting viral growth in cell lines, marking it as a promising candidate for future COVID-19 treatments.
In addition to the Indian patent, the team has filed two international patents and received two German patents for related research. Their relentless efforts, which began in the early days of the pandemic, highlight a promising pathway for inhibiting the growth of SARS-CoV-2, BHU said.
Drawing on the therapeutic properties of these traditional Ayurvedic ingredients, the formulation has shown considerable efficacy in preliminary studies. The next steps will involve testing in animal models, followed by clinical trials to evaluate its effects in humans.
BHU patent
The patent recognizes the efforts of a distinguished team led by professor Parimal Das, alongside PhD scholars Prashant Ranjan, Neha, Chandra Devi, and Prashasti Yadav, as well as Dr Garima Jain (Malaviya Post Doctoral Fellow), Dr Chandana Basu Malick (Wellcome Trust Fellow), and Dr Bhagyalaxmi Mohapatra (department of zoology). This collaborative achievement underscores the potential of Ayurvedic phytomolecules in modern medical research.
Also read 4 private universities ahead of all IITs together in patent applications
Professor Das expressed optimism about the formulation, stating, “This achievement reflects the dedication and hard work of our team. We are hopeful that it can provide a natural solution to combat SARS-CoV-2.”
This groundbreaking discovery, rooted in Ayurvedic science, offers renewed hope in the ongoing global battle against the pandemic and showcases the commitment of young researchers dedicated to this critical project, added the university.
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Next Story
]Featured News
]- Delhi University to allow students to complete a semester at a foreign university
- Delhi University’s 4-year degree students may have option to complete PG in 1 year
- Interest in MDI Gurgaon’s EMBA growing, attracts learners from across professions
- NTA Overhaul: 1,000 secure exam centres, biometrics to prevent fraud, question paper changes, suggests panel
- What changes in NEET UG? Experts’ panel suggests multi-stage exam, security overhaul, simpler process to NTA
- Use KVs, JNVs as NEET, JEE Main exam centres: High Level Committee on NTA
- Maharashtra cluster universities may now comprise only self-financed colleges; government tables Bill
- National Testing Agency exam count dropped by over 50% in 2024; lowest in 5 years
- NIOS Exams: Over 35,000 cheating cases reported since 2022, education ministry tells Lok Sabha
- South Asian University plans more online degrees, course, to start arts, management faculties